ILAR Reclassification Study

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

9 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

This study hopes to revise the currently used criteria for diagnoses of Juvenile Idiopathic Arthritis (JIA). This study aims to follow children newly diagnosed with JIA for up to five years. We will ask for a small blood sample for the first two visits, and for participants to fill out a back assessment. We will also record disease information from your medical record.

Eligibility & Criteria

IRB #:
19-016267
Official Title:
The PRINTO Evidence-based Revision of the International League Against Rheumatism (ILAR) Classification criteria for juvenile idiopathic Arthritis
Study Phase:
Not Applicable
Eligible Age Range:
0 - 16 Years
Gender:
All
Study Categories:
Leader
Pamela F. Weiss

Pamela F. Weiss, MD, MSCE